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Department of Biochemistry KATP channels activate under metabolic stress such as
University of California, San Francisco hypoxia, ischemia, and metabolic inhibition and protect
San Francisco, California 94143 heart, brain, and muscle cells against ischemic injury
(Nichols and Lederer, 1991; Pang et al., 1997; Yamada
and Inagaki, 2002). For example, ischemia causes aden-
osine to accumulate in the heart, brain, and kidney (Mu-Summary
bagwa et al., 1996; Mubagwa and Flameng, 2001; Nieber
et al., 1999; Reshef et al., 1998; Shryock and Belardinelli,ATP-sensitive potassium (KATP) channels activate un-
1997), leading to tissue protection likely due to PKCder metabolic stress to protect neurons and cardiac
activation (Simkhovich et al., 1998; Schulz et al., 2001).myocytes. However, excessive channel activation may
PKC stimulates KATP channels in cardiac myocytes (Hucause arrhythmia in the heart and silence neurons in
et al., 1996; Light et al., 1996; Liu et al., 1996) and recom-the brain. Here, we report that PKC-mediated down-
binant KATP channels, most likely by phosphorylatingregulation of KATP channel number, via dynamin-
Kir6.2 at threonine 180 (Light et al., 2000). The protectiondependent channel internalization, can act as a brake
afforded by KATP activation to central neurons and car-mechanism to control KATP activation. A dileucine motif
diac myocytes during ischemia is largely due to energyin the pore-lining Kir6.2 subunit of KATP, but not the
preservation (Yamada et al., 2001; Wann, 1993) and re-site of PKC phosphorylation for channel activation, is
duced Ca2 influx (Edwards and Weston, 1993; Hearse,essential for PKC downregulation. Whereas KATP acti-
1995).vation results in a rapid shortening of the action poten-
tial duration (APD) in metabolically inhibited ventricu- While activation of KATP channels during metabolic
lar myocytes, adenosine receptor stimulation and stress is protective against injury, excessive KATP chan-
consequent PKC-mediated KATP channel internaliza- nel opening may have deleterious consequences. In the
tion can act as a brake to lessen this APD shortening. heart, active KATP channels cause the action potential
Likewise, in hippocampal CA1 neurons under meta- duration (APD) to shorten and contribute to cellular K
bolic stress, PKC-mediated, dynamin-dependent KATP loss, both risk factors for arrhythmia (Janse and Wit,
channel internalization can also act as a brake to 1989; Wilde, 1993). In the brain, opening of KATP channels
dampen the rapid decline of excitability due to KATP in neurons results in hyperpolarization and reduced ex-
activation. citability, raising the risk of silencing the neurons (Ya-
mada et al., 2001). It is therefore important to understand
how KATP channels might be regulated under metabolicIntroduction
stress to confer protection without incurring serious
damage.ATP-sensitive potassium (KATP) channels control insulin
In this study, we ask whether adenosine and PKCrelease and blood flow and may protect muscle, heart,
might modulate KATP channels in ways other than theirkidney, and brain under metabolic stress (Noma, 1983;
known involvement in channel activation. To explore theSeino, 1999; Ashcroft, 1988; Schwanstecher et al., 1999;
effects of PKC activation, we first employed the phorbolTerzic et al., 1995; Nelson and Quayle, 1995). KATP chan-
ester 4--phorbol 12-myristate 13-acetate (PMA) andnel inhibition by ATP and stimulation by nucleotide di-
found that 15–30 min PMA treatments reduced KATPphosphates allows the membrane potential and excit-
channel activity by promoting channel internalization viaability to be regulated by the metabolic state of the cell.
dynamin-dependent endocytosis. Having determinedThe KATP channel contains four pore-lining subunits of
that the pore-lining Kir6.2 subunit is the primary targetthe Kir6 subfamily of inwardly rectifying potassium
channels (Tucker et al., 1997) and four regulatory sub- for PKC-mediated downregulation, we mutated PKC
units of the ATP binding cassette (ABC) superfamily. consensus sites in Kir6.2 including T180 and found no
The regulatory subunits, the sulphonylurea receptors effect on channel downregulation by PKC. Instead, we
(SUR), mediate channel inhibition by sulphonylurea found a dileucine motif in Kir6.2 to be important for
drugs such as glibenclamide (Aguilar-Bryan and Bryan, constitutive as well as PKC-induced channel internaliza-
1999; Babenko et al., 1998; Seino, 1999; Fujita and Kura- tion, in cultured cardiac myocytes as well as COS-7
chi, 2000; Loussouarn et al., 2002; Tucker and Ashcroft, cells. The physiological significance for such a brake
1998). Differences in endogenous KATP channel proper- against excessive KATP activation is underscored by its
ties and pharmacology (Edwards and Weston, 1993) ability to retard not only APD shortening in metabolically
may be accounted for by differences in subunit compo- inhibited ventricular myocytes but also loss of excitabil-
ity of hippocampal CA1 neurons under metabolic inhi-
bition.*Correspondence: gkw@itsa.ucsf.edu
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Figure 1. PKC Activation by PMA Pretreatment Downregulates ATP-Sensitive K Channels via Channel Internalization
(A) PMA pretreatment for 30 min decreases azide-induced K current measured at 60 mV in Xenopus oocytes expressing Kir6.2 and SUR1/
2A. Left panel with representative traces shows current reduction after pretreatment with PMA (100 nM) but not the inactive congener 4-PDD
(100 nM). Recordings were made using a ramp protocol between 120 and 40 mV every 5 s. Right panel shows averaged current amplitudes
measured after 10 min superfusion with azide (3 mM) (MI, metabolic inhibition) from oocytes pretreated with PMA, 4-PDD, or PMA plus
chelerythrine (10 M). **p  0.01.
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Results subsequently treated with PMA or PMA plus chele-
rythrine for 30 min at 37C, then fixed, permeabilized,
and labeled with fluorescent secondary antibodies atPMA Causes a Reduction of Surface KATP Channels
in Xenopus Oocytes and COS-7 Cells room temperature. Most of the labeled channels ap-
peared to have remained on the plasma membrane ifExposing oocytes expressing Kir6.2 and SUR1/2A to
the metabolic inhibitor sodium azide (3 mM) for 10 min cells were not exposed to PMA. In contrast, significant
endocytosis of KATP channels followed the PMA treat-induced the KATP current, with a somewhat variable time
course of onset. This azide-induced current was signifi- ment, as indicated by the shift of antibody-labeled chan-
nels from the plasma membrane to numerous endocyticcantly reduced by 100 nM PMA pretreatment (Figure
1A). This KATP downregulation was evident when cells vesicles inside the cell (Figure 1C). The PKC inhibitor
chelerythrine prevented PMA from causing channel in-were exposed to PMA (100 nM) for 15 min (Figure 1B,
right panel; 75.5%  6.2% for Kir6.2 and SUR1 and ternalization (Figure 1C), indicating that endocytosis of
KATP channels is induced by PKC activation.78.6%  8.1% for Kir6.2 and SUR2A, p  0.05 versus
control [MI], n	 7); stronger effects were observed after
30 min of PMA treatment (Figures 1A and 1B, right panel; Distribution of Internalized KATP Channels
Following PKC Activation53.3%  7.4% for Kir6.2 and SUR1 and 55.8%  6.7%
for Kir6.2 and SUR2A, p  0.01 versus control [MI], n 	 Different endocytic markers were used in double label-
ing experiments to characterize the vesicles containing7). We have therefore carried out all the quantitative
analyses following 30 min of PMA treatment. No reduc- endocytosed KATP channels marked with antibodies ap-
plied to live cells. First, live cells were exposed to rhoda-tion resulted from treatment with the inactive congener
4--phorbol 12,13-didecanoate (4-PDD, 100 nM) (Fig- mine-conjugated WGA (wheat germ agglutinin) to label
surface glycoproteins, some of which were subse-ure 1A; n 	 7). The PKC inhibitor chelerythrine (10 M)
prevented the downregulation by PMA (Figure 1A, right quently internalized. Following PMA treatment, endocy-
tosed KATP channels colocalized with WGA (Figure 2A).panel; n	 7), consistent with the notion that PKC activa-
tion by PMA decreases KATP currents. There was also partial overlap between endocytosed
channels and GFP-Rab7 (Figure 2B), a marker for lateA decrease in KATP current may result from alteration of
either channel function or channel number. To examine endosomes and lysosomes (Bucci et al., 2000), indicat-
ing that some of the internalized channels may be tar-whether PMA affects the KATP channel number, we quan-
tified surface KATP channel proteins with the hemaggluti- geted for degradation.
Many housekeeping receptors such as the transferrinnin (HA) epitope inserted in an extracellular loop of
Kir6.2, via a chemiluminescence assay (Zerangue et al., receptor rapidly recycle to the cell surface via recycling
endosomes (Mukherjee et al., 1997) in a Rme1-depen-1999). PMA treatment caused a significant, 2-fold reduc-
tion in surface channel number in oocytes (Figure 1B, dent process (Grant et al., 2001; Lin et al., 2001). Expres-
sion of the dominant-negative Rme1 (G429R) mutanttop left panel) (41.5%  6.2% for Kir6.2 and SUR1 and
44.3%  9.1% for Kir6.2 and SUR2A, n 	 8, p  0.01 significantly slowed recycling of transferrin receptors,
causing their accumulation in the Rme1-associated re-versus control). Similar reduction was observed for
channels expressed in COS-7 cells (Figure 1B, lower left cycling compartment (Figure 3A). By contrast, there was
relatively minor overlap between internalized channelspanel) (53.2% 5.4% for Kir6.2 and SUR1 and 49.1%
4.3% for Kir6.2 and SUR2A, n 	 7, p  0.01 versus and the default recycling pathway marked by Rme1
(G429R) (Figure 3A).control). No reduction was observed when cells were
exposed to PMA together with the PKC inhibitor chele- To further explore the mechanism for PKC-induced
channel endocytosis, we tested the effect of expressingrythrine (10 M) (Figure 1B, lower left panel; n 	 6). The
inactive congener 4-PDD (100 nM) also had no effect the dominant-negative mutant dynamin 1 (K44E). Dis-
ruption of dynamin function blocked PKC downregula-(Figure 1B, lower left panel; n	 7). These results indicate
that the PKC downregulation of channel activity could tion of KATP channels on the COS-7 cell surface (Figure
3B, left panel; p  0.01 versus PMA alone, n 	 6) andbe accounted for by a 2-fold reduction in the number
of channels on the cell membrane. prevented PKC from reducing KATP current in metaboli-
cally inhibited oocytes (Figure 3B, right panel; p  0.01
versus PMA alone, n 	 8). These findings suggest thatPMA Facilitates Endocytosis of KATP Channels
in COS-7 Cells PKC promotes KATP channel internalization by dynamin-
dependent endocytosis.A plausible mechanism for the observed reduction in
surface channel number is that PKC stimulates channel
internalization. To test this possibility, we transiently A Dileucine Motif in Kir6.2 Is Essential for PKC
to Promote Internalization of Kir6.2 and SUR1/2Atransfected COS-7 cells with HA-tagged Kir6.2 and
SUR1/2A, then treated live cells with primary antibodies The KATP channel is composed of two different types of
subunit, Kir6.2 and SUR1/2A (Figure 4A, top panel). Toagainst the extracellular HA epitope. These cells were
(B) Chemiluminescence measurement of channels containing HA-tagged Kir6.2 and SUR1/2A on the surface of nonpermeabilized oocytes
(top left), COS-7 cells (lower left), and time course of PMA-induced reduction of channel proteins on the COS-7 cell surface (right). PMA (100
nM) treatment for 15, 30, or 60 min significantly reduces cell surface expression. **p  0.01, *p  0.05.
(C) PMA (100 nM) facilitates endocytosis of channels containing HA-tagged Kir6.2 and SUR1/2A in transiently transfected COS-7 cells. The
PKC inhibitor chelerythrine (Che, 10 M) blocks the PMA effect. Scale bar equals 15 m.
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Figure 2. Partial Overlap of Endocytosed KATP
Channels with Endocytosed Wheat Germ Ag-
glutinin or the Late Endosome Marker GFP-
Rab-7
(A) Application of HA antibody to live cells
label surface KATP channels with an extracellu-
lar HA epitope, revealing that most channels
that are internalized following PMA (100 nM)
treatment accumulate in intracellular vesicles
that also contain endocytosed rhodamine-
WGA. Scale bar equals 15 m; WGA, wheat
germ agglutinin.
(B) A small portion of these endocytosed
channels colocalizes with the late endosome/
lysosome marker GFP-Rab-7. Scale bar
equals 15 m.
test whether PKC can downregulate channels con- acids of Kir6.2. Dileucine motifs mediate endosomal tar-
geting by interacting with the AP2 adaptor protein com-taining only Kir6.2 subunits, we removed the RKR signal
for ER retention/retrieval (Schwappach et al., 2000; Zer- plex (Sandoval et al., 1994; Trowbridge et al., 1993).
Indeed, mutating this dileucine sequence of Kir6.2 (355-angue et al., 1999), either by alanine substitutions or by
deleting the last 36 residues of Kir6.2 (Kir6.2
36) (Tucker 356LL-AA) caused an increase of surface octameric
channels (Figure 4B, right panel; 126.5%  9.2% foret al., 1997; Figure 4A, lower panel), and expressed tetra-
meric Kir6.2 channels without SUR. Cell surface expres- mutant Kir6.2 and SUR1 and 130.2% 10.9% for mutant
Kir6.2 and SUR2A, n 	 8, p  0.05 versus wild-type),sion of HA-tagged Kir6.2
36 was not altered by PMA
treatment (Figure 4B, left panel; 104.5%  6.3%, n 	 suggesting that the dileucine motif plays a role in consti-
tutive channel endocytosis. Interestingly, these mutant7). In contrast, alanine substitution of LRKR in Kir6.2
(Kir6.2C4A) yielded tetrameric channels that were down- channels no longer responded to PMA treatment with
a decrease in cell surface expression (Figure 4B, rightregulated by the PMA treatment (Figure 4B, left panel;
69.7% 4.7%, n	 7, p 0.05 versus Kir6.2C4A without panel; 121.1% 12.3% for mutant Kir6.2 and SUR1 and
132.7%  10.9% for mutant Kir6.2 and SUR2A, n 	PMA). Thus, PKC downregulates tetrameric Kir6.2 chan-
nels as well as octameric KATP channels, and the last 8). These mutant channels also yielded similar azide-
induced KATP currents with or without PMA treatment36 amino acids of Kir6.2 harbor sequences crucial for
channel downregulation by PKC. (Figure 4C). Moreover, PMA treatment of COS-7 cells
failed to induce internalization of KATP channels lackingA dileucine motif is located within the last 36 amino
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Figure 3. Dynamin-Dependent PKC-Induced
Channel Endocytosis with Partial Overlap of
Internalized Channels and the Recycling En-
dosomal Marker GFP-Rme1 (G429)
(A) Expression of a dominant-negative Rme1
mutant, Rme1 (G429R), inhibits recycling of
transferrin receptors but does not cause sig-
nificant accumulation of channels in the com-
partment that contains transferrin receptors
and GFP-Rme1 (G429R). Scale bar equals
15 m.
(B) Dominant-negative dynamin mutant
(K44E) blocks PMA-induced reduction of sur-
face KATP channels in COS-7 cells (left) and
similar reduction of KATP current at 60 mV
after 10 min metabolic inhibition of oocytes
coexpressing Kir6.2 and SUR1/2A (right).
**p  0.01.
the dileucine motif (Figure 4D). These results strongly ure 5C and data not shown). PKC phosphorylates pri-
marily T180, causing channel activation (Light et al.,suggest that the dileucine motif in Kir6.2 functions in
constitutive endocytosis as well as PKC-induced inter- 2000). These findings present interesting contrast with
desensitization of G protein-coupled receptors (GPCR);nalization of KATP channels.
To test whether Kir6.2 phosphorylation and activation whereas GPCR activation and ensuing phosphorylation
of the activated receptors is a prerequisite for their inter-by PKC is a prerequisite for channel internalization, we
examined the effect of PMA on COS-7 cells expressing nalization (Claing et al., 2002), KATP channel activation via
PKC phosphorylation is not required for PKC-inducedKATP channels with mutated PKC consensus sites in
Kir6.2 (Figure 5A; T180A, T224A, T336A, or T345A) channel internalization.
(Kemp and Pearson, 1990). PMA reduced the surface
expression of these mutant KATP channels by half (Figure PKC Stimulates Internalization of KATP Channels
in Cardiac Myocytes5B), as in the case of wild-type KATP channels. Moreover,
KATP channels lacking any one or all four PKC consensus KATP channels in cardiac myocytes are stimulated within
5 min by acute PKC activation by PMA (Hu et al., 1996);sites were still internalized following PMA treatment (Fig-
Neuron
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Figure 4. A Dileucine Motif in Kir6.2 Is Re-
quired for PMA-Induced Endocytosis of KATP
Channels
(A) Schematic depiction of Kir6.2 and SUR1/
2A membrane topology (top) and Kir6.2 resi-
dues mutated in this study (underlined)
(bottom).
(B) Chemiluminescence measurements of
surface protein level in COS-7 cells express-
ing HA-tagged Kir6.2
C36 or Kir6.2C4A alone
(left) or HA-tagged Kir6.2 with its dileucine
replaced with alanines (Kir6.2LL-AA) together
with SUR1/2A (right) reveal that PMA (100 nM)
fails to stimulate endocytosis of channels
without the dileucine motif in Kir6.2. *p 0.05,
**p  0.01.
(C) Replacing dileucine with alanines pre-
vents PMA from reducing azide-induced K
current recorded at 60 mV in Xenopus oo-
cytes. Left panel shows representative
traces. Right panel shows average inward
current measured at 60 mV after 10 min
metabolic inhibition, following 30 min pre-
treatment with PMA (100 nM), 4-PDD (100
nM), or PMA plus chelerythrine (10 M). Re-
cordings in oocytes were made using a ramp
protocol between 120 and 40 mV every 5 s.
(D) PMA treatment does not result in signifi-
cant endocytosis of channels containing
Kir6.2LL-AA and SUR1/2A. Scale bar equals
15 m.
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Figure 5. Potential PKC Phosphorylation Site(s) of Kir6.2 Are Not Required for PKC-Mediated Endocytosis
(A) Consensus sites for PKC phosphorylation in Kir6.2.
(B) Chemiluminescence measurement reveals a 2-fold reduction of surface protein level by PMA (100 nM) in COS-7 cells expressing HA-
tagged Kir6.2 mutants (T180A, T224A, T336A, and T345A) and SUR1/2A.
(C) Representative immunofluorescence staining showing that mutating potential phosphorylation sites (T180A, T345A) in Kir6.2 does not
prevent PMA-induced endocytosis of channels containing HA-tagged Kir6.2 and SUR1/2A. Scale bar equals 15 m.
20 min after establishing whole-cell patch-clamp re- effects of a dominant-negative dynamin peptide (D10)
on action potentials in adult rat ventricular myocytes.cording with 400 M ATP in pipette solution to reduce
the cytosolic ATP level, PMA (100 nM) was added to the D10 is a 10 amino acid peptide that interferes with the
binding of amphiphysin with dynamin, thereby dis-bath, causing activation of KATP current within 5 min
(Figure 6A). In contrast, pretreatment of ventricular myo- rupting dynamin-dependent endocytosis (Kittler et al.,
2000). For control, we used a scrambled peptide of thecytes with PMA for 30 min reduced the KATP current
induced by metabolic inhibition (Figure 6B). Conse- same amino acid composition, S10. The D10 or S10
peptide was added to the solution in the patch clampquently, whereas cardiac KATP channel activation causes
action potentials to shorten during ischemia or meta- electrode and allowed to diffuse into the cardiac myo-
cyte under whole-cell patch clamp for 20 min beforebolic inhibition (Nichols and Lederer, 1991; Wilde, 1993),
PMA pretreatment reduced action potential shortening these myocytes were treated with PMA for 30 min. There
were no significant alterations in APD90 after dialyzingof myocytes exposed to glucose-free solutions con-
taining the metabolic inhibitors cyanide (2 mM) and peptides into the myocytes or after the subsequent PMA
treatment for 30 min (Figure 6D, top panel). Thus, these2-deoxy-glucose (10 mM) (Figure 6C; n 	 7). The 30 min
PMA pretreatment did not affect the resting membrane treatments had no detectable effects on cardiac chan-
nels other than KATP channels, which remained quiescentpotential (83.5  5.3 mV, n 	 21) nor the shape or
duration of action potentials prior to metabolic inhibition in healthy myocytes. Eight minutes of metabolic inhibi-
tion caused more severe reduction of APD90 in PMA-(MI) (data not shown). Thus, whereas PKC pretreatment
does not appear to affect channels that are active in treated cells dialyzed with D10, compared to PMA-
treated cells dialyzed with S10 (Figure 6D; 13.8  1.4healthy myocytes, it reduces the extent of endogenous
KATP channel activation during metabolic stress. ms for D10 group versus 32.8  2.4 ms for S10 group,
p  0.01, n 	 8). Therefore, the effect of PKC on APDTo test whether PKC downregulates endogenous KATP
channels by promoting internalization, we examined the shortening is dynamin dependent.
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Figure 6. Channel Activation due to Brief PKC Activation by PMA in Contrast to Dynamin- and Dileucine-Dependent Channel Downregulation
due to Prolonged PKC Activation in Rat Ventricular Myocytes
(A) Acute PMA (100 nM) treatment for 5 min greatly increases KATP current recorded in ventricular myocytes with 400 M ATP in the whole-
cell patch-clamp pipette solution. The KATP channel blocker glibenclamide (Glib, 10 M) blocks this current, and the PKC inhibitor chelerythrine
(Che, 10 M) blocks the PMA effect. Representative whole-cell currents are shown, from a holding potential of 40 mV to 300 ms voltage
pulses between 100 mV and 50 mV. Dotted lines indicate zero current levels.
(B) PKC activation by PMA (100 nM) pretreatment for 30 min reduces metabolic inhibition (cyanide plus 2-deoxyglucose)-induced KATP current
in rat ventricular myocytes. Subsequent addition of glibenclamide (Glib) blocks this current. Same voltage-clamp protocol as in (A).
(C) Shortening of action potential duration in rat ventricular myocytes exposed to metabolic inhibitors cyanide and 2-deoxy glucose is due
PKC Promotes KATP Channel Internalization
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Further support for a role of PKC in channel traffic chelerythrine (14.2  1.8 ms, n 	 6, p  0.01 versus
adenosine group).regulation was obtained in neonatal ventricular myo-
cytes transfected with HA-tagged Kir6.2 and SUR2A. Adenosine (100 M)-induced endocytosis of KATP
channels was readily detected in neonatal rat ventricularThe PMA pretreatment for 30 min induced endocytosis
of the HA-tagged channels (Figure 6E), causing part of myocytes expressing channels with extracellular HA tag.
This adenosine effect was also sensitive to the PKCthese internalized channels to reside in Rab7-positive
late endosomes (Figure 6F). Moreover, PKC-induced inhibitor chelerythrine (Figure 7C). Furthermore, KATP
channels internalized following adenosine treatmentchannel internalization in these neonatal ventricular
myocytes required the dileucine endocytic motif of showed partial overlap with the late endosome/lyso-
some marker GFP-Rab7 (Figure 7D), as expected forKir6.2 (Figure 6E).
PKC can be activated by adenosine in vivo. Adenosine PKC downregulation of the channel. Taken together,
these findings indicate that adenosine induces KATPaccumulates in tissues under metabolic stress (Mu-
bagwa and Flameng, 2001). Adenosine released into channel internalization in cardiac myocytes by activat-
ing adenosine receptors and the downstream PKC, athe interstitial fluid in metabolically stressed heart could
activate various adenosine receptor subtypes that are process that could partially counter runaway KATP chan-
nel activation during metabolic inhibition and hence re-coupled to multiple effectors including enzymes, chan-
nels, and transporters. Indeed, PKC activation has been duce the detrimental effects due to APD shortening.
implicated in adenosine-mediated events such as isch-
emic preconditioning (Downey and Cohen, 1997). It is PKC Stimulates Internalization of Endogenous
KATP Channels in Hippocampal CA1 Neuronsthus plausible that adenosine receptor activation may
stimulate PKC in cardiac myocytes and cause KATP chan- We next tested whether adenosine causes endogenous
KATP channel downregulation in a PKC-dependent man-nel internalization. We tested this scenario by adding
adenosine to isolated ventricular myocytes. ner in central neurons and, if so, whether PKC-mediated
downregulation of neuronal KATP channels is dynaminFirst, we found that PMA or adenosine pretreatment
for 30 min reduced endogenous KATP currents in meta- dependent. To approach these questions, we recorded
from cultured hippocampal slices. Healthy CA1 neuronsbolically stressed adult rat ventricular myocytes (Figure
7A). Metabolic inhibition with cyanide activated KATP cur- had a resting potential of 55.3  2.1 mV (n 	 25;
Figure 8A) and, when depolarized, fired action potentialsrent that was significantly blocked by 10 M glibencla-
mide (1.02  0.13 nA in MI versus 0.21  0.03 nA in MI repeatedly (Figure 8B), both in neurons dialyzed with the
scrambled control peptide S10 and in neurons dialyzedplus glibenclamide, p  0.01, n 	 5). PMA pretreatment
significantly reduced this KATP current (0.47  0.06 nA with the dominant-negative dynamin peptide D10 via
the whole-cell patch-clamp electrode. PKC pretreatmentin PMA followed with MI versus MI group, p  0.01, n 	
7). Adenosine pretreatment also reduced KATP current for 30 min did not affect these properties, indicating
little effect on channels that are active in these healthyactivated by metabolic inhibition (Figure 7A, left panel;
0.56  0.08 nA in adenosine followed with MI versus MI neurons.
Metabolic inhibition with 0.5 mM cyanide caused hy-group, p  0.01, n 	 7). The PKC inhibitor chelerythrine
blocked this adenosine-induced KATP current reduc- perpolarization of CA1 neurons; 10 M glibenclamide
blocked this hyperpolarization due to endogenous KATPtion (Figure 7A, right panel). Thus, adenosine can acti-
vate endogenous PKC to downregulate cardiac KATP channel activation (Figure 8A;69.53.2 mV in MIS10
versus 57.4  2.9 mV in MIGlibS10 group, p channels.
Next, we found that adenosine significantly reduced 0.01, n 	 8). It also caused a gradual decrease in firing
rate of action potentials in the CA1 neurons dialyzedAPD shortening after 8 min exposure of adult ventricular
myocytes to metabolic inhibitors (35.7  4.1 ms for with S10, resulting in action potential failure within 5 min
of metabolic inhibition (Figure 8B, left panel). Gliben-adenosine followed with MI [adenosine group] and 9.3
1.2 ms for MI, n	 6, p 0.01; Figure 7B). This adenosine clamide (10 M) prevented cyanide-induced decrease
in firing rate, indicating that the loss of excitability resultseffect was abolished by the adenosine receptor antago-
nist 8-phenyltheophyline (8-PT) (8.9 1.1 ms, n	 6, p from KATP channel activation during metabolic stress.
PMA pretreatment for 30 min allowed metabolically in-0.01 versus adenosine group) and by the PKC inhibitor
to activation of KATP channels, as indicated by the effect of the KATP channel blocker glibenclamide (Glib, 10 M). Pretreatment with PMA (100
nM) for 30 min significantly reduces action potential shortening induced by metabolic inhibition. Action potentials were elicited by 2 ms twice-
threshold pulses every 5 s. Top panel shows representative traces and bottom panel shows the averaged data. Che indicates chelerythrine
(10 M). **p  0.01.
(D) The dominant-negative dynamin peptide D10 (100 M in patch-clamp pipette solution) diffuses into cardiac myocyte after establishment
of whole-cell recording (time 0) and prevents the PMA (100 nM) pretreatment (time 20–50 min) from reducing the shortening of APD90% due
to metabolic inhibitors cyanide (2 mM) and 2-deoxy glucose (10 mM) (MI, top panel). The average APD90% before (control, Ctrl) and 8 min
into MI (bottom panel) reveals that D10 but not scrambled peptide S10 (100 M) prevents PMA from reducing the shortening of APD90%
caused by MI. **p  0.01 for MI  PMA, D10 versus S10 (bracket).
(E) PMA (100 nM) treatment for 30 min induces endocytosis of channels containing SUR2A and HA-tagged Kir6.2 but not Kir6.2LL-AA in
primary culture of rat neonatal ventricular myocytes. The PKC inhibitor chelerythrine (Che, 10 M) blocks the PMA effect. Scale bar equals
20 m.
(F) Endocytosed HA-tagged Kir6.2 and SUR2A induced by PMA (100 nM) treatment for 30 min shows partial overlap with late endosome/
lysosome marker GFP-Rab7 in cardiac myocytes. Scale bar equals 20 m.
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Figure 7. Adenosine Causes PKC-Dependent Endocytosis of Both Transfected and Endogenous KATP Channels in Rat Ventricular Myocytes
(A) PKC activation by adenosine significantly reduces MI-induced activation of KATP current. Pretreatment for 30 min with adenosine (Ade)
significantly reduces MI-induced activation of KATP current in rat ventricular myocytes (holding potential, 40 mV; 300 ms voltage pulses
between 100 mV and 50 mV) (left). Average KATP current amplitude at 50 mV before (control, Ctrl) or 8 min into MI in the absence or presence
of Glib (10 M) or pretreatment with PMA (100 nM), PMA plus Che (10 M), ade (100 M), or ade plus Che (right). **p  0.01.
(B) Average action potential duration at 90% repolarization in rat ventricular myocytes. Adenosine significantly reduces action potential
shortening 8 min after the onset of metabolic inhibition. Action potentials were elicited by 2 ms twice-threshold pulses. **p  0.01.
(C) Adenosine (Ade, 100 M)-induced endocytosis of HA-tagged Kir6.2 and SUR2A expressed in neonatal rat ventricular myocytes is blocked
by the adenosine receptor antagonist 8-PT (10 M) and the PKC inhibitor chelerythrine (Che). Scale bar equals 20 m.
(D) Endocytosis of HA-tagged Kir6.2 and SUR2A induced by adenosine shows partial overlap with late endosome/lysosome marker GFP-
Rab7 in cardiac myocytes. Scale bar equals 20 m.
hibited neurons dialyzed with S10 to continue firing ac- cells dialyzed with D10, PMA treatment no longer had
any effect on action potentials (Figure 8B, right panel).tion potentials (Figure 8B, left panel), consistent with
the notion of PKC downregulation of KATP channels. In PKC activation by PMA also reduced cyanide-induced
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Figure 8. PKC-Induced, Dynamin-Dependent,
Downregulation of KATP Channels in Hippo-
campal Neurons May Be Triggered by Aden-
osine
(A) Hyperpolarization of the resting mem-
brane potential (RMP) due to metabolic inhi-
bition (MI)-induced KATP activation is reduced
by PMA in a dynamin-dependent manner.
Left panel shows a representative time
course of changes in RMP. Right panel shows
mean data before (control, Ctrl) and 5 min
into MI in cells dialyzed with either S10
(scrambled peptide, 100 M) or D10 (domi-
nant-negative dynamin peptide, 100 M) un-
der whole-cell patch clamp, and pretreated
with PMA (100 nM) or PMA plus chelerythrine
(Che, 10 M). The dominant-negative dy-
namin peptide completely blocks the PMA
effect.
(B) The number of action potentials evoked
by 400 ms current pulses of 200 pA is reduced
to zero following 5 min of metabolic inhibition
(MI) in hippocampal neurons dialyzed with
S10 (100 M, left) under whole-cell patch-
clamp. This reduction in excitability is due
to KATP activation and can be prevented by
application of glibenclamide (Glib, 10 M).
PMA (100 nM) pretreatment partially blocks
the reduction of AP firing frequency in meta-
bolically inhibited neurons containing S10
(left) but not in metabolically inhibited neu-
rons containing the dominant-negative dy-
namin peptide D10 (100 M, right).
(C) Metabolic inhibition (MI)-induced whole-
cell currents recorded at 60 mV for 300 ms
from a holding potential of 70 mV in hippo-
campal neurons. The MI-induced current is
blocked by KATP inhibitor glibenclamide (10
M) and reduced by PMA pretreatment (100
nM, left). Statistically significant reduction of neuronal KATP is induced by PMA or adenosine (100 M). The adenosine as well as the PMA
effects are blocked by the PKC inhibitor Che (10 M). **p  0.01.
hyperpolarization (61.1  3.0 mV in PMAMIS10 nel internalization in a dynamin-dependent manner,
thereby rescuing metabolically stressed neurons fromversus MIS10 group, p  0.05, n 	 8), an effect that
was eliminated by D10 (70.2  3.7 mV in an imminent loss of excitability.
PMAMID10 versus PMAMIS10 group, p  0.05,
n 	 8) (Figure 8A, right panel). These findings suggest Discussion
that the PMA effect is due to dynamin-dependent inter-
nalization of KATP channels by PKC. PKC Regulates KATP Channel Trafficking
KATP channels mediate protection against ischemic injuryTo further verify that PKC treatment of CA1 neurons
downregulates endogenous KATP channels, we recorded in the heart and brain (Miki et al., 2002; Suzuki et al.,
2002; Yamada et al., 2001; Hiraoka and Furukawa, 1998;whole-cell KATP currents during a 300 ms step to 60
mV from a holding potential of 70 mV (Figure 8C). Rejdak et al., 2001). Therapeutic agents such as sulpho-
nylurea drugs also target these channels (Edwards andMetabolic inhibition with cyanide (0.5 mM) induced KATP
current (200.5  25.4 pA in MI versus 51.2  5.3 pA in Weston, 1993; Fujita and Kurachi, 2000). Given that
channel activity depends critically on the number ofcontrol, p  0.01, n 	 7) that was blocked by glibencla-
mide (62.1 6.3 pA, n	 7). PMA or adenosine treatment functional channels, traffic regulation could be an impor-
tant, though still poorly understood, mechanism of KATPsignificantly decreased the endogenous KATP currents
(127.7  16.5 pA in PMAMI versus MI group, p 0.01, channel modulation. Our study reveals that PKC activa-
tion downregulates KATP channels in cardiac myocytesn 	 7; 134.8  13.2 pA in AdeMI versus MI group, p 
0.01, n 	 7). Downregulation by adenosine or PMA was and central neurons, most likely by promoting channel
internalization. Importantly, KATP channels endogenousblocked by the PKC inhibitor chelerythrine (213.5 26.7
pA in PMACheMI and 189.3  20.1 pA in Ade to the cardiac myocytes and hippocampal neurons may
be downregulated by adenosine and its downstreamCheMI group, n 	 7). Thus, metabolic inhibition with
cyanide causes hyperpolarization of CA1 neurons and effector PKC. Our findings, therefore, identify a brake
against excess channel activation by removing some ofdepression of neuronal activity by activating KATP chan-
nels. Activation of endogenous PKC reduces neuronal the KATP channels from the plasma membrane. This traf-
fic regulation provides a negative feedback in controllingKATP channel activity most likely by promoting KATP chan-
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K efflux and APD shortening in cardiac myocytes, and ized epithelial cells (Pond et al., 1995). Dileucine motifs
may also target proteins from the plasma membranein maintaining neuronal excitability in the brain. It may
afford the heart cells with a means to delay or avoid to endosomes (Bremnes et al., 1994; Letourneur and
Klausner, 1992; Sandoval et al., 1994). This motif is rec-ventricular arrhythmia, the major cause of mortality from
coronary artery disease (Goldman and Cook, 1984). It ognized by AP2 (Heilker et al., 1996). Phosphorylation
of threonine 156 of the 2 subunit of the AP2 complexmay also prevent or reduce a rapid descent of central
neurons into dormancy (Alzheimer and ten Bruggencate, is essential for endocytosis (Olusanya et al., 2001). The
endogenous2 kinase is most likely the adaptor-associ-1988).
KATP channels may be modulated by many factors in- ated kinase 1 (AAK1), although cyclin G-associated ki-
nase (GAK) has also been implicated (Smythe, 2002).cluding ATP, ADP, protons, and G protein-coupled re-
ceptors such as adenosine receptors (Mubagwa et al., Whether PKC might act upstream of these kinases is
not known. Interestingly, myocardial PKC is associated1996; Shryock and Belardinelli, 1997). PKC can either
inhibit or activate KATP channels in several noncardiac with adaptin-, which is at much elevated levels in trans-
genic mice with enhanced cardioprotection due to thetissues, depending on the time course of experiment and
signaling pathway involved (Bonev and Nelson, 1993; de expression of constitutively active PKC (Ping et al.,
2001).Weille et al., 1989; Dunne, 1994; Honore and Lazdunski,
1993; Wang and Giebisch, 1991). In cardiac myocytes,
several studies have consistently shown that brief (5 to Physiological Implications in the Brain
10 min) PKC activation stimulates KATP channel function, and the Heart
due to phosphorylation of T180 in Kir6.2 (Wang and The physiological relevance of our findings is suggested
Lipsius, 1995; Hu et al., 1996; Liu et al., 1996; Light et from the ability of adenosine and the downstream PKC
al., 1996, 2000; Hu et al., 1999). We have found that to downregulate endogenous KATP in both cardiac myo-
prolonged PKC activation (15 to 30 min) downregulates cytes and central neurons, thereby reducing cardiac
KATP channel function via channel internalization. Thus, APD shortening and sustaining neuronal activity. Adeno-
PKC has dual effects on KATP channel modulation: activa- sine accumulates during ischemia and locally mediates
tion of surface channels via channel phosphorylation the protection due to KATP channel activation (Mubagwa
and reduction of surface channel number by promoting and Flameng, 2001; Nieber et al., 1999; Reshef et al.,
channel internalization. It is generally accepted that PKC 1998). Adenosine A1- and A3-receptors, identified as
may serve as a central mediator in ischemic precondi- part of the mechanism for preconditioning, are coupled
tioning, which causes prolonged elevation of PKC activ- to PKC through the activation of G protein and phospho-
ity during subsequent ischemia (Nakano et al., 2000). lipase C (PLC) or D (PLD) (Schulz et al., 2001). PLC
Our findings suggest a potential role for the regulation activation is typically very rapid in onset, and the re-
of KATP channel trafficking as a mechanism for providing sulting DAG production is short-lived, peaking at 30 s.
cytoprotection against ischemia, possibly by optimizing In contrast, PLD activation is delayed but accounts for
the number of active KATP channels on the cell surface. prolonged production of DAG and prolonged activation
Although the data presented are consistent with a role of PKC. It is therefore likely that PLD rather than PLC
for this mechanisms in vivo, further experiments will be is involved in adenosine-mediated KATP channel internal-
required to demonstrate directly the contribution of this ization.
mechanism to a physiological context. KATP activation by PKC has been associated with aden-
osine-mediated protection both in the heart and brain
(Blondeau et al., 2000; Perez-Pinzon and Born, 1999;PKC-Induced KATP Channel Internalization Is Dynamin
Dependent and Requires a Dileucine Motif in Kir6.2, Schulz et al., 2001). Activation of KATP channels causes
APD shortening in the heart (Nichols et al., 1991). APDbut not Channel Activation by PKC Phosphorylation
We have shown that PKC-mediated KATP channel inter- shortening has been proposed to be one of the mecha-
nisms for the protective effects of KATP channel openingnalization is dynamin dependent but appears to be inde-
pendent of Kir6.2 phosphorylation. Moreover, we have during metabolic stress (Edwards and Weston, 1993;
Hearse, 1995). The beneficial effect of KATP channelidentified a dileucine internalization motif that is required
for PKC-induced KATP internalization. Mutation of dileu- opening may also involve processes other than APD
shortening (Grover et al., 1995), such as hyperpolariza-cine in Kir6.2, when coexpressed with SUR1/2A, signifi-
cantly increased the cell surface channel number in the tion (Suzuki et al., 2002). Notwithstanding the rapid ac-
tion of adenosine and PKC in activating KATP channels,absence of PKC activation. It also prevented PKC from
causing KATP channel endocytosis. Thus, the dileucine chronic elevation of PKC activity confers cardiac protec-
tion in transgenic mice (Dorn et al., 1999; Ping et al.,motif is involved in constitutive endocytosis as well as
PKC-mediated internalization of KATP channels. Interest- 2001). Similarly, chronic treatment with adenosine up-
take inhibitors causes sustained cardioprotectioningly, PKC-induced channel internalization does not de-
pend on phosphorylation in Kir6.2. This may allow PKC against ischemia/reperfusion injury (Mubagwa and Fla-
meng, 2001). It would be of interest to examine in theseto remove a fraction of KATP channels from the cell mem-
brane regardless of their state of activation by PKC, in cases the possible contribution of channel traffic regu-
lation.a process that runs in parallel to but is temporally and
mechanistically independent of KATP channel activation KATP channels are present in many brain regions
(Mourre et al., 1991; Schwanstecher and Panten, 1993;via PKC phosphorylation.
Dileucine signals may target membrane proteins from Ashford et al., 1990; Guatteo et al., 1998). These chan-
nels may exert protection against neurodegenerationTGN to endosomes or the basolateral surface of polar-
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Primary culture of 90% pure cardiac ventricular myocytes wasor neuronal death during ischemia (Liss et al., 1999a,
prepared from the heart of 1-day-old rats according to the method1999b). Loss of KATP channel function in Kir6.2 knockout
of Simpson et al. (Simpson and Savion, 1982). The cell suspensionmice results in hypoxia-induced generalized seizure (Ya-
was finally plated onto 3.5 cm collagen-coated coverslips at a den-
mada et al., 2001). The protective effect of KATP channels sity of 2  105 per 35 mm dishes. Adherent viable myocytes con-
has been associated with hyperpolarization and re- tracted spontaneously 24 hr after plating. Neonatal ventricular myo-
cytes were transfected using FuGENE6 3 days after cell preparation.duced excitability in neurons (Hansen et al., 1982; Alz-
Cells were stained 2 days after transfection. Rhodamine-labeledheimer and ten Bruggencate, 1988; Ashcroft and Ash-
phalloidin (1:200, Sigma), which binds to the myofibrils with a char-croft, 1990; Perez-Pinzon et al., 1996; Reshef et al., 1998;
acteristic cross-striated pattern, was used to distinguish myocyteYamada et al., 2001). On the other hand, excessive KATP from nonmyocyte cells in the culture. Nonmyocyte cells were less
channel activation may contribute to depression of than 10% of total cells.
higher brain functions by hypoxia or cerebral ischemia, Rat ventricular myocytes were isolated from adult SD rats (200
to 300 g, Charles River) by enzymatic dissociation, with methodsresulting in disorientation and loss of consciousness
similar to those previously described (Hu et al., 1996). Hippocampal(Rossen et al., 1943). KATP channel activation causes
slices (400 m) were cut from postnatal 6- to 8-day-old rats withhyperpolarization and complete cessation of spontane-
tissue chopper and cultured in medium as described (Shi et al.,ous electrical activity in dopaminergic SN neurons
1999).
(Roper and Ashcroft, 1995; Yamada et al., 2001). In brain
slice preparations, hypoxia or metabolic inhibition Quantitative Chemiluminescence Detection of Proteins
causes hyperpolarization and reduced excitability in on the Surface of Oocytes and COS7 Cells
hippocampal neurons (Theodore et al., 1991; Englund Chemiluminescence measurement of HA-tagged surface proteins
has been previously described (Zerangue et al., 1999). Treatmentet al., 2001), due to an increase in KATP conductance
with PMA or other interventions was done by incubation at 37C(Godfraind and Krnjevic, 1993; Hyllienmark and Brismar,
prior to fixation. For Xenopus oocytes, cells were prepared and1996). Similar to our observations in ventricular myo-
maintained as previously described (Collins et al., 1997). Two to
cytes, we found that adenosine likely activates PKC in three days after oocytes were injected with 1 ng cRNA for Kir6.2
hippocampal neurons to cause KATP channel internaliza- constructs and 5 ng for SUR1/2A constructs, oocytes were blocked,
tion, so as to provide a brake against rapid loss of neu- labeled with primary antibody, and then washed and incubated with
HRP-coupled secondary antibody. Individual oocytes were placedronal activity.
in 50 l Power Signal Elisa (Pierce) and incubated at room tempera-Our observations uncover an important adaptive
ture for 1 min before the measurement. For COS7 cells, cells platedmechanism allowing KATP channels to be downregulated in 35 mm tissue culture dishes were transfected with FuGENE and
by prolonged PKC activation via traffic regulation. This surface expression of all constructs was assayed 2–3 days after
braking mechanism may play a critical role in regulating transfection as previously described (Margeta-Mitrovic et al., 2000).
KATP channel function to overcome metabolic stress, Cells were fixed, blocked, and then labeled with primary antibody
(3F10) for 1 hr and with an appropriate HRP-coupled secondarythough its implication in heart and brain physiology and
antibody for 20 min. Chemiluminescence for cells in the whole 35pathology requires careful scrutiny given the complexity
mm dish was quantified after 15 s incubation in Power Signal Elisaof cardiac and neuronal protection during ischemia.
solution. Chemiluminescence for both oocytes and COS7 cells was
Given that Kir6.2 is the subunit common to KATP channels quantified using a TD-20/20 luminometer (Turner Designs). For the
in the pancreas, heart, and brain, the regulation of KATP detection of HA-tagged proteins, we used anti-HA rat monoclonal
channel trafficking by PKC characterized in this study antibody (3F10, Roche, 0.2g/ml) and goat anti-rat HRP-conjugated
F(ab’)2 fragments (Jackson, 1:1000 dilution).is likely to be of general relevance. Our studies provide
evidence that, in parallel with KATP channel activation
Immunofluorescenceunder metabolic stress, KATP channels in cardiac myo-
COS7 cells were blocked with 5% goat serum in PBS (30 min atcytes and central neurons are regulated at the level of
4C) labeled with primary antibody (2 hr at 4C). Cells were then
trafficking to control the extent of channel activation. treated with PMA or other interventions for 30 min at 37C, fixed
with 4% formaldehyde in PBS (30 min), blocked in 5% goat serum
Experimental Procedures in PBS with 0.1% Triton X-100 (30 min), and labeled with secondary
antibody (1 hr); after cells were fixed, all steps were done at room
Molecular Biology temperature. We used anti-HA monoclonal rat primary antibody
The HA epitope was introduced into mouse Kir6.2 cDNA by sequen- (3F10, Roche, 1 g/ml) and Cy3- or Cy2-conjugated donkey anti-
tial overlap extension polymerase chain reaction (PCR) as described rat secondary antibody (Jackson, 1:500). Immunofluorescence was
by Zerangue et al. (1999). The epitope was inserted at position 102 visualized with a Nikon inverted microscope.
of Kir6.2. The 11 amino acids (98GDLYAYMEKGIT99) were inserted
into Kir6.2 before the HA epitope. The Kir6.2
36, Kir6.2C4A (LRKR- Electrophysiology
AAAA, 368–371), and Kir6.2LL-AA (355–356) mutant constructs were For Xenopus oocytes, recordings were made 3–5 days after cRNA
generated by PCR. All PCR-derived sequences were entirely se- injection using standard two-electrode voltage clamp technique.
quenced. Mammalian expression constructs were all in pcDNA3 KATP currents were recorded in the solution containing (in mM) 90
(Invitrogen). For oocyte expression, constructs were either in KCl, 10 Na HEPES, 1.8 CaCl2, 1.0 MgCl2 (pH 7.4) and determined
pGEMHE (Liman et al., 1992) or in pGEMHEm (Margeta-Mitrovic et by subtracting control current (60 mV) from currents recorded
al., 2000). cRNA was transcribed using T7 RNA polymerase. after 10 min application of 3 mM sodium azide. Oocytes were treated
with PMA or other reagents prior to recordings. All recordings in
oocytes were made using a ramp protocol between 120 and 40Cell Isolation and Cell Culture
COS7 cells were cultured in Dulbecco’s modified Eagle’s medium mV every 5 s for time course measurement.
For cardiac ventricular myocytes, all cells for electrophysiologicalDMEM/F12 (Mediatech) supplemented with 10% fetal bovine serum
(FBS), 2 mM glutamine, and penicillin-streptomycin (cell culture fa- measurements were rod-shaped and showed clear cross striations.
The bath solution contains (mM) 135 NaCl, 5.4 KCl, 1.0 MgCl2, 1.0cility, UCSF). Cells were grown on coverslips for immunofluores-
cence and in 35 mm tissue culture dishes for chemiluminescence CaCl2, 0.33 NaH2PO4, 10 HEPES, and 10 glucose at pH 7.4 (pH
adjusted with NaOH). The pipette solution contained (mM) 120 Kassay of surface protein. Cells were transfected with FuGENE6
(Roche) and stained 2–3 days later. glutamate, 25 KCl, 1.0 MgCl2, 10 HEPES, 5 EGTA, 0.1 GTP, and 1
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K2ATP at pH 7.3 (pH adjusted with KOH) except that 0.4 mM K2ATP epileptic preconditioning are stress signals inducing hippocampal
neuroprotection. Neuroscience 100, 465–474.was added to the pipette solution for the studies on the effect of
acute PKC activation. Whole-cell KATP currents were recorded using Bonev, A.D., and Nelson, M.T. (1993). Muscarinic inhibition of ATP-
voltage-clamp technique. CdCl2 (0.2 mM) and 4-aminopyridine (2 sensitive K channels by protein kinase C in urinary bladder smooth
mM) were added to the bath solution to inhibit Ca2 current and muscle. Am. J. Physiol. 265, C1723–C1728.
transient outward current, respectively. In current-clamp mode, ac-
Bremnes, B., Madsen, T., Gedde-Dahl, M., and Bakke, O. (1994).
tion potentials were elicited by 2 ms twice-threshold pulses and
An LI and ML motif in the cytoplasmic tail of the MHC-associated
were recorded every 5 s. APD90 were compared in various groups. invariant chain mediate rapid internalization. J. Cell Sci. 107, 2021–
All recordings were conducted at room temperature (21C to 25C).
2032.
For hippocampal CA1 neurons, slices were transferred to the
Bucci, C., Thomsen, P., Nicoziani, P., McCarthy, J., and van Deurs,recording chamber perfused with physiological solution (21C–25C)
B. (2000). Rab7: a key to lysosome biogenesis. Mol. Biol. Cell 11,containing (mM) 119 NaCl, 2.5 KCl, 2.5 CaCl2, 1.3 MgSO4, 26 NaHCO3,
467–480.1 NaH2PO4, 11 glucose at pH 7.4 and gassed with 5% CO2 and
Claing, A., Laporte, S.A., Caron, M.G., and Lefkowitz, R.J. (2002).95% O2. Patch recording pipettes were filled with internal solutions
Endocytosis of G protein-coupled receptors: roles of G protein-containing (mM) 140 K gluconate, 5 HEPES, 2 MgCl2, 1.1 EGTA, 1
coupled receptor kinases and beta-arrestin proteins. Prog. Neuro-Na2ATP, 3 Na3GTP, at pH 7.25. Cells were held in either voltage-
biol. 66, 61–79.clamp mode for recording whole-cell KATP currents or current-clamp
for action potentials. A depolarizing current pulse (400 ms, 200 pA) Collins, A., Chuang, H., Jan, Y.N., and Jan, L.Y. (1997). Scanning
was applied to elicit action potentials in the current-clamp mode. mutagenesis of the putative transmembrane segments of Kir2.1, an
inward rectifier potassium channel. Proc. Natl. Acad. Sci. USA 94,
Chemicals and Statistical Analysis 5456–5460.
Group data are expressed as mean  SE. Unpaired t test or ANOVA de Weille, J.R., Schmid-Antomarchi, H., Fosset, M., and Lazdunski,
with a range test (the least significant difference test) compare the M. (1989). Regulation of ATP-sensitive K channels in insulinoma
data between groups. Differences with a two-tailed value of p  cells: activation by somatostatin and protein kinase C and the role
0.05 were considered statistically significant. of cAMP. Proc. Natl. Acad. Sci. USA 86, 2971–2975.
Collagenase (Type II) was purchased from Worthington. Other
Dorn, G.W., Souroujon, M.C., Liron, T., Chen, C.H., Gray, M.O., Zhou,
chemicals were purchased from Sigma. PMA and 4-PDD were
H.Z., Csukai, M., Wu, G., Lorenz, J.N., and Mochly-Rosen, D. (1999).
stored in ethanol at 20C. The KATP channel blocker glibenclamide Sustained in vivo cardiac protection by a rationally designed peptide
were stored in DMSO. Other chemicals were stored in distilled H2O. that causes  protein kinase C translocation. Proc. Natl. Acad. Sci.
Dominant-negative dynamin peptide D10 (QVPSRPNRAP) and
USA 96, 12798–12803.
scrambled peptides S10 (PRAPNSRQPV) were dissolved at 100 M
Downey, J.M., and Cohen, M.V. (1997). Signal transduction in isch-in the internal solution (pipette solution).
emic preconditioning. Adv. Exp. Med. Biol. 430, 39–55.
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